Atsuko Fujihara

912 total citations
92 papers, 579 citations indexed

About

Atsuko Fujihara is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Atsuko Fujihara has authored 92 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pulmonary and Respiratory Medicine, 26 papers in Surgery and 16 papers in Urology. Recurrent topics in Atsuko Fujihara's work include Prostate Cancer Diagnosis and Treatment (35 papers), Prostate Cancer Treatment and Research (26 papers) and Urinary Bladder and Prostate Research (12 papers). Atsuko Fujihara is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (35 papers), Prostate Cancer Treatment and Research (26 papers) and Urinary Bladder and Prostate Research (12 papers). Atsuko Fujihara collaborates with scholars based in Japan, United States and Germany. Atsuko Fujihara's co-authors include Osamu Ukimura, Tsuneharu Miki, Fumiya Hongo, Koji Okihara, Kazumi Kamoi, Masayuki Kurooka, Yasufumi Kaneda, Yasuhiro Yamada, Tsuyoshi Iwata and Takumi Shiraishi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Atsuko Fujihara

81 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atsuko Fujihara Japan 14 281 128 121 103 94 92 579
J. NEWMAN United Kingdom 11 97 0.3× 279 2.2× 72 0.6× 44 0.4× 72 0.8× 28 667
Peter A. Drew United States 13 244 0.9× 389 3.0× 141 1.2× 86 0.8× 54 0.6× 38 701
Alexander J. Gallan United States 14 292 1.0× 63 0.5× 12 0.1× 37 0.4× 191 2.0× 39 673
Aylin Gül Türkiye 12 67 0.2× 159 1.2× 18 0.1× 46 0.4× 64 0.7× 55 410
Shijun Zhao China 13 233 0.8× 32 0.3× 45 0.4× 45 0.4× 129 1.4× 48 569
Karin Hofmann Germany 13 211 0.8× 217 1.7× 80 0.7× 13 0.1× 171 1.8× 31 773
Galliano Tinacci Italy 10 70 0.2× 112 0.9× 37 0.3× 23 0.2× 67 0.7× 21 366
I. Alonso Spain 24 145 0.5× 503 3.9× 30 0.2× 69 0.7× 114 1.2× 65 1.2k
Madhu Mati Goel India 13 83 0.3× 190 1.5× 22 0.2× 40 0.4× 86 0.9× 65 461
Hiroto Matsuoka Japan 12 287 1.0× 52 0.4× 10 0.1× 33 0.3× 144 1.5× 26 581

Countries citing papers authored by Atsuko Fujihara

Since Specialization
Citations

This map shows the geographic impact of Atsuko Fujihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuko Fujihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuko Fujihara more than expected).

Fields of papers citing papers by Atsuko Fujihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuko Fujihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuko Fujihara. The network helps show where Atsuko Fujihara may publish in the future.

Co-authorship network of co-authors of Atsuko Fujihara

This figure shows the co-authorship network connecting the top 25 collaborators of Atsuko Fujihara. A scholar is included among the top collaborators of Atsuko Fujihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsuko Fujihara. Atsuko Fujihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsujimoto, Masashi, Yumiko Saito, Masatomo Kaneko, et al.. (2025). MRI‐Determined Tumor Contact Area as a Predictor of Pathological Extraprostatic Extension in Clinical T2 Prostate Cancer. PubMed. 2025(1). 9165949–9165949.
3.
Yamazaki, Hideya, Gen Suzuki, Koji Masui, et al.. (2024). The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy. Scientific Reports. 14(1). 8011–8011. 1 indexed citations
4.
Ueda, Takashi, et al.. (2024). Apalutamide versus bicalutamide in combination with androgen deprivation therapy for metastatic hormone sensitive prostate cancer. Scientific Reports. 14(1). 705–705. 4 indexed citations
5.
Kaneko, Masatomo, Atsuko Fujihara, Tsuyoshi Iwata, et al.. (2024). A nomogram to predict the absence of clinically significant prostate cancer in males with negative MRI. International braz j urol. 50(3). 319–334. 5 indexed citations
7.
Yamazaki, Hideya, Gen Suzuki, Koji Masui, et al.. (2023). Ultra-High Prostate-Specific Antigen Level: A Potential Very-High-Risk Factor for Localized High-Risk Prostate Cancer. Cancers. 15(23). 5644–5644.
8.
Naitoh, Yasuyuki, et al.. (2023). Factors affecting testicular volume after orchiopexy for undescended testes. Journal of Medical Ultrasonics. 50(4). 493–499. 1 indexed citations
9.
11.
Kaneko, Masatomo, Yasuhiro Yamada, Eiichi Konishi, et al.. (2022). Microwave focal therapy of prostate cancer: a non‐clinical study and exploratory clinical trial. British Journal of Urology. 130(6). 776–785. 8 indexed citations
13.
Naitoh, Yasuyuki, et al.. (2021). Robot‐assisted laparoscopic pyeloplasty for ureteropelvic junction obstruction due to aberrant blood vessel with ipsilateral retrocaval ureter. SHILAP Revista de lepidopterología. 4(5). 273–276. 3 indexed citations
14.
Yamazaki, Hideya, Gen Suzuki, Koji Masui, et al.. (2021). Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors. Cancers. 13(14). 3486–3486. 2 indexed citations
15.
Nakamura, Yuichi, et al.. (2020). Sphere-derived Prostate Cancer Stem Cells Are Resistant to γδ T Cell Cytotoxicity. Anticancer Research. 40(10). 5481–5487. 14 indexed citations
16.
Matsugasumi, Toru, Takumi Shiraishi, Atsuko Fujihara, et al.. (2020). Targeted Focal Cryoablation for Prostate Cancer With Real-time Transrectal Ultrasound-guided Free-hands Technique: A Step-by-step Technique. Urology. 144. 261–262. 2 indexed citations
17.
Yamada, Yasuhiro, Akihisa Ueno, Masatomo Kaneko, et al.. (2019). Phase I study of cancer lesion-targeted microwave coagulation therapy for localized prostate cancer: A pilot clinical study protocol. Contemporary Clinical Trials Communications. 16. 100471–100471. 7 indexed citations
18.
Matsugasumi, Toru, Osamu Ukimura, Masahiko Nakamoto, et al.. (2014). Impact of morphometric analysis of prostate zonal anatomy on lower urinary tract symptom: Cooperative analysis of MRI-prostate in USA and Japan. Neurourology and Urodynamics. 1 indexed citations
19.
Naya, Yoshio, Akihiro Kawauchi, Takashi Ueda, et al.. (2014). Comparison of diameter-axial-polar nephrometry and RENAL nephrometry score for treatment decision-making in patients with small renal mass. International Journal of Clinical Oncology. 20(2). 358–361. 10 indexed citations
20.
Ukimura, Osamu, Motohiro Kanazawa, Atsuko Fujihara, et al.. (2008). Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia with special reference to the storage symptom: A prospective randomized controlled study. International Journal of Urology. 15(12). 1049–1054. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026